ZOZO Balance Sheet Health

Financial Health criteria checks 6/6

ZOZO has a total shareholder equity of ¥77.3B and total debt of ¥20.0B, which brings its debt-to-equity ratio to 25.9%. Its total assets and total liabilities are ¥158.6B and ¥81.3B respectively. ZOZO's EBIT is ¥57.7B making its interest coverage ratio 800.8. It has cash and short-term investments of ¥50.5B.

Key information

25.9%

Debt to equity ratio

JP¥20.00b

Debt

Interest coverage ratio	800.8x
Cash	JP¥50.51b
Equity	JP¥77.29b
Total liabilities	JP¥81.27b
Total assets	JP¥158.56b

Recent financial health updates

Is ZOZO (TSE:3092) Using Too Much Debt?

Apr 21

Recent updates

Financial Position Analysis

Short Term Liabilities: 3092's short term assets (¥119.6B) exceed its short term liabilities (¥72.4B).

Long Term Liabilities: 3092's short term assets (¥119.6B) exceed its long term liabilities (¥8.9B).

Debt to Equity History and Analysis

Debt Level: 3092 has more cash than its total debt.

Reducing Debt: 3092's debt to equity ratio has reduced from 108.9% to 25.9% over the past 5 years.

Debt Coverage: 3092's debt is well covered by operating cash flow (183.4%).

Interest Coverage: 3092's interest payments on its debt are well covered by EBIT (800.8x coverage).

Balance Sheet

Discover healthy companies

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

ZOZO Balance Sheet Health

Financial Health criteria checks 6/6

Key information

Recent financial health updates

Is ZOZO (TSE:3092) Using Too Much Debt?

Recent updates

Is ZOZO (TSE:3092) Using Too Much Debt?

Is Now An Opportune Moment To Examine ZOZO, Inc. (TSE:3092)?

Upcoming dividend of JP¥49.00 per share

Now 20% overvalued after recent price rise

ZOZO (TSE:3092) Is Due To Pay A Dividend Of ¥49.00

ZOZO, Inc. to Report Fiscal Year 2024 Results on Apr 30, 2024

ZOZO, Inc.'s (TSE:3092) Share Price Could Signal Some Risk

Now 21% overvalued after recent price rise

Third quarter 2024 earnings: EPS in line with analyst expectations despite revenue beat

ZOZO, Inc. Revises Dividend Guidance for the Fiscal Year Ending March 31, 2024

ZOZO, Inc. to Report Q3, 2024 Results on Jan 31, 2024

ZOZO, Inc. (TSE:3092) announces an Equity Buyback for 5,000,000 shares, representing 1.67% for ¥10,000 million.

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

ZOZO, Inc. Announces Dividend for the Second Quarter End of Year Ending March 31, 2024, Payable on November 27, 2023; Provided Dividend Guidance for the Fiscal Year Ending March 31, 2024

Upcoming dividend of JP¥28.00 per share at 2.5% yield

ZOZO, Inc. to Report Q2, 2024 Results on Oct 31, 2023

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Full year 2023 earnings: Revenues and EPS in line with analyst expectations

ZOZO, Inc. to Report Q1, 2024 Results on Jul 31, 2023

ZOZO, Inc. Proposes Year End Dividend for Fiscal Year 2023

Full year 2023 earnings: Revenues and EPS in line with analyst expectations

Upcoming dividend of JP¥41.00 per share at 2.1% yield

ZOZO, Inc. to Report Fiscal Year 2023 Results on Apr 27, 2023

Zozo, Inc. Provides Dividend Guidance for the Year Ending March 31, 2023

Third quarter 2023 earnings released: EPS: JP¥40.51 (vs JP¥33.73 in 3Q 2022)

ZOZO, Inc. Revises Dividend Guidance for the Year Ending March 31, 2023

ZOZO, Inc. to Report Q3, 2023 Results on Jan 31, 2023

Second quarter 2023 earnings: EPS exceeds analyst expectations

Less than half of directors are independent

Second quarter 2023 earnings: EPS exceeds analyst expectations

ZOZO, Inc. Announces Dividend for the Second Quarter of Fiscal Year Ending March 31, 2023, Payable on November 28. 2022

Upcoming dividend of JP¥24.00 per share

ZOZO, Inc. Launches Zozofit 3D Body Measurement System to Revolutionize Fit Technology in Fitness and Body Transformation

ZOZO, Inc. to Report Q2, 2023 Results on Oct 28, 2022

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

ZOZO, Inc. Provides Consolidated Earnings Guidance for the Fiscal Full Year Ending March 31, 2022

Investor sentiment improved over the past week

Now 20% undervalued after recent price drop

Full year 2022 earnings: EPS misses analyst expectations

ZOZO, Inc. Appoints Masahiro Tashiro as Executive Officer

Full year 2022 earnings: EPS misses analyst expectations

ZOZO, Inc. Provides Year End Dividend Guidance for the Year Ending March 31, 2023

Now 29% undervalued after recent price drop

Less than half of directors are independent

Now 22% undervalued after recent price drop

Upcoming dividend of JP¥33.00 per share

Now 22% undervalued after recent price drop

ZOZO, Inc. to Report Fiscal Year 2022 Results on Apr 27, 2022

Third quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

ZOZO, Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2022

Now 21% undervalued after recent price drop

Second quarter 2022 earnings released: EPS JP¥26.21 (vs JP¥21.69 in 2Q 2021)

Upcoming dividend of JP¥22.00 per share

First quarter 2022 earnings released: EPS JP¥28.91 (vs JP¥23.98 in 1Q 2021)

Full year 2021 earnings released: EPS JP¥101 (vs JP¥61.59 in FY 2020)

ZOZO, Inc. (TSE:3092) announces an Equity Buyback for 8,544,000 shares, representing 2.8% for ¥32,000 million.

ZOZO, Inc. Provides Dividend Guidance for the Second Quarter of Fiscal Year Ending March 31, 2022 and Full Fiscal Year Ending March 31, 2022

Full year 2021 earnings released: EPS JP¥101 (vs JP¥61.59 in FY 2020)

ZOZO, Inc. Provides Consolidated Earnings Guidance for the Full Year Ended March 31, 2022

ZOZO, Inc. Revises Year End Dividend Guidance for the Full Year Ending March 31, 2022

Upcoming dividend of JP¥23.00 per share

New 90-day high: JP¥3,630

Investor sentiment improved over the past week

ZOZO, Inc. Launches ZOZOCOSME

Third quarter 2021 earnings released: EPS JP¥32.03 (vs JP¥13.93 in 3Q 2020)

Revenue and earnings beat expectations

Zozo, Inc. Revises Financial Guidance of the Fiscal Year Ending March 31, 2021

New 90-day high: JP¥2,994

Price target raised to JP¥2,995

ZOZO, Inc. to Report Q3, 2021 Results on Jan 29, 2021

ZOZO Inc. Launches ZOZOSUIT 2, a 3D body measurement suit, and opens its measurement technologies, ZOZOSUIT 2 and the ZOZOMAT for business partnership

ZOZO, Inc. to Report Q2, 2021 Results on Oct 29, 2020

Zozo, Inc. Resumes Its Operations

Financial Position Analysis